Why Advocacy is Vital

Categories: Support News, Uncategorized, Volunteer

In this article, Trish Caruana, Vice President – Patient and Carepartner Advocacy explains what advocacy is, and the common hurdles people face when considering advocacy. Care, consciousness and cure are central to the mission of CurePSP, but how we advocate for people with PSP and other prime of life diseases is also important. The lack of …

Read More

Breakthrough in clearing toxic misfolded tau, in the Daily-Star, Jan 26

Categories: Uncategorized

          With $100 million from Rainwater family, brain research hits stride BY STEVE KASKOVICH, Star-Telegram, January 26 More than a year after Fort Worth billionaire Richard Rainwater lost his battle with a degenerative brain disease, his quest to find a cure is making progress. A group of top doctors and neuroscientists …

Read More

Anti-Tau Antibody Trial Enters Phase 2!

Categories: Uncategorized

AbbVie Initiates Phase 2 Clinical Trial Programs for ABBV-8E12, an Investigational Anti-Tau Antibody, in Early Alzheimer’s Disease and Progressive Supranuclear Palsy Jan 25, 2017 Courtesy of AbbVie, January 2017   – Initiation of Phase 2 clinical trial programs in early Alzheimer’s disease and progressive supranuclear palsy (PSP) is part of ongoing commitment to investigate ABBV-8E12 …

Read More

CurePSP receives $200,000 from Nesbitt Charitable Foundation to fund two studies.

Categories: Uncategorized

CurePSP donor funds two innovative studies of PSP Nesbitt grant supports research into both care and cure   New York, NY (November 16, 2016) — CurePSP, the leading nonprofit advocacy organization focused on prime of life neurodegenerative diseases, has received a donation from the Nesbitt Charitable Fund, Houston, Texas, of $200,000 to fund two research …

Read More

CurePSP Receives Matching Grant Challenge for Genetics Research

Categories: Research News, Uncategorized

Friedman family has committed up to $600,000 New York, NY (June 29, 2016) — CurePSP, the leading nonprofit advocacy organization focused on prime of life neurodegenerative diseases, today announced a matching grant challenge of up to $600,000 from the Friedman family to accelerate genetics research. An initial contribution of $250,000 toward this goal has been …

Read More